The new report suggests that the global migraine treatment market is coming out with two new pharmaceutical agents and pending drugs that will improve the market moderately over the coming years. The market is estimated to grow from USD 2.5 billion in 2012 to USD 3.7 billion by 2023, recording an annual compound growth rate of 3.6%.
United States remains dominant
As per the research on the migraine market, United States remains dominant with more than 77% market share and is expected to further increase its lead by 2023 reaching up to 84% of the total market. All the new drugs are developed to provide an alternative route of administration to the existing formulations for treating the acute problems involved with the disease. The drugs that contain the sumatriptan iontophoretic transdermal system like Teva, Zecurity and NuPathe and dihydroergotamine (Levadex, Allergan) AVP-825 (sumatriptan, OptiNose) and SUD-001 (sumatriptian oral spray, and SUDA) are being adopted by the medical fraternity as a means of naturopathic treatment. Besides this, there are other ditan and gepant drug classes which will soon be available in the market for the patients who don’t respond to the available acute migraine therapy.
All the recent developments in the migraine drug market are expected to spur the growth the market size since the developing therapies have the potential to steal the market shares from the existing drugs like triptans and ergot alkaloids. The developments are awaited with much anticipation because Botox remains the sole prophylactic treatment for chronic migraine for the foreseeable future.
For further insights,
Visit: http://www.researchonglobalmarkets.com/migraine-pipeline-review-h1-2014.html
About Research on Global Markets
Research on Global Markets is a leading source for market research on various sectors globally, offering premium research content from worldwide publishers of market research reports. Our database hosts premium market research content developed by global publishers. It offers premium industry research reports, company profiles and country briefs. We have a dedicated team of research professionals who can facilitate, in an unbiased manner, the process of identifying appropriate market research reports that are targeted to fulfill all your information-related requirements.
For more details on the content of each report and ordering information please contact:
Email: customerservice@researchonglobalmarkets.com
US: +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE: Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com
Video:
No comments:
Post a Comment